Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal stem cell renewal is the process by which undifferentiated stem cells located in the basal layer of the epidermis or in the hair follicle bulge undergo self-renewal divisions and produce progenitor cells that differentiate into mature keratinocytes, thereby ensuring the maintenance and repair of the skin barrier[1][2][3][4]. These stem cells are characterized by slow-cycling, high proliferative potential, and expression of specific markers such as β1 integrin, α6 integrin (CD49f), and keratins CK15/CK19. The renewal dynamics are tightly regulated: differentiation of a stem cell leads to compensatory division of neighboring cells, balancing homeostasis[1]. Aberrations in these processes are implicated in wound healing deficiencies and skin cancers[2][4]. This entry is marked "is_incorrect: true" because "Epidermal stem cell renewal" refers to a process or phenomenon, not a specific protein, receptor, or druggable target. For structured molecular targeting, focus should be on specific markers, signaling receptors (like Lgr6), or structural proteins (such as integrins) expressed by epidermal stem cells[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal stem cell renewal (EpiSC).